Benefit of extended maintenance therapy for venous thromboembolism with dabigatran etexilate is maintained over 1 year of post-treatment follow-up

Pas encore traduit Pas encore traduit
Catégorie Primary study
JournalBlood
Year 2012

Cet article est inclus dans 2 Systematic reviews Systematic reviews (2 references)

This article is part of the following publication threads:
  • RE-COVER I [Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism] (15 documents)
  • RE-COVER II [Phase III Study Testing Efficacy and Safety of Oral Dabigatran Etexilate versus Warfarin for 6 Month Treatment for Acute Symptomatic Venous Thromboembolism (VTE)] (12 documents)
This article is part of the following matrixes of evidence:
Loading references information
Cet article n'a pas de résumé
Epistemonikos ID: 146c10f39a0412b1f38cbe28b3f1f122a3f3be1c
First added on: May 17, 2016